Interferon for hepatitis C

Lancet

Volumn 349, Issue 9049, 1997, Pages 398-399

  Puoti, Claudio ^a   Magrini, Andrea ^b   Stati, Tonino ^b   Rossi, Piero ^b   Montagnese, Fabrizio ^b   Resta, Salvatore ^b  

^a E De Santis Hospital   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON;

ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HUMAN; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0031046982     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)80016-5     Document Type: Article

References (4)

1. Van Thiel DH, Caraceni P, Molloy PJ, et al. Chronic hepatitis C with normal or near normal alanine aminotransferase levels: the role of interferon α2b therapy. J Hepatol 1995; 23: 503-08.
2. Booth JCL, Brown JL, Thomas HC. The management of chronic hepatitis C infection. Gut 1995; 37: 449-54.
3. Serfaty L, Chazouillères O, Pawlotsky JM, et al. Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity. Gastroenterology 1996; 110: 291-95.
4. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696-99.